Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
Authors:
Open Access
- 12 December 2013
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 110 (2) , 297-303
Abstract
Intensity-modulated radiotherapy (IMRT) is the main salvage treatment for advanced locally recurrent nasopharyngeal carcinoma (NPC); however, survival outcomes vary. We aimed to construct a prognostic-score model to identify patients who could benefit from salvage IMRT. This retrospective study involved 251 patients with locally recurrent NPC. The following parameters were analysed following IMRT: patient performance status, age, gender, late complications, T-stage of recurrence, synchronous nodal recurrence, primary gross tumour volume (GTV-nx), disease-free interval, re-irradiation dose and chemotherapy. The model was based on the hazard ratio coefficients of six significantly negative prognostic factors for survival. Significantly negative prognostic factors included Karnofsky Performance Status 70, age >50 years, late complications, recurrent T3–4 stage, synchronous nodal recurrence and GTV-nx >30 cm3. Three subgroups were defined according to model scores: low risk (0–4), intermediate risk (5–8) and high risk (9–15). The 5-year overall survival rates were 64.3%, 32.2% and 7.7%, respectively. The main cause of death was radiation-induced complications. The prognostic-score model demonstrated that re-irradiation with IMRT is suitable for low-risk and intermediate-risk patients but may be unsuitable for high-risk patients. Further research into the protection of critical adjacent organs to reduce late complications in these patients is warranted.Keywords
This publication has 28 references indexed in Scilit:
- Intensity-Modulated Radiation Therapy in the Salvage of Locally Recurrent Nasopharyngeal CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancerRadiation Oncology, 2011
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinomaHead & Neck, 2009
- Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic VarietyJournal of Clinical Oncology, 2005
- Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study: Is combined modality treatment really necessary?Radiotherapy and Oncology, 2002
- Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- How Successful Is High-Dose (≥60 GY) Reirradiation Using Mainly External Beams in Salvaging Local Failures of Nasopharyngeal Carcinoma?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998